NAVAMEDIC ASA: årsregnskap 2025 vs 2024
Grew 28% on revenue, weaker earnings, cash halved-plus
approved 2026-04-23; registry 2026-07-27; journal 2026 675106
Summary
What changed
Comparing Årsregnskap 2025 with 2024 for NAVAMEDIC ASA. Revenue 52.80m NOK → 67.35m NOK (+27.5%). Net result -16.66m NOK → -23.54m NOK. Equity 177.21m NOK → 280.11m NOK.
On the constructive side: revenue rose; equity strengthened; owners injected capital. Pressures included: operating result weakened; net result weakened; cash fell.
Also worth watching: payroll increased; cogs fell. All figures are taken from the published annual accounts for NAVAMEDIC ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 52.80m NOK to 67.35m NOK (+27.5% YoY). Calculated
-
↑
Equity strengthened
Book equity 177.21m NOK → 280.11m NOK (equity ratio 34.6% → 37.1%). Calculated
-
↑
Owners injected capital
Paid-in equity rose 211.31m NOK → 332.20m NOK (+120.89m NOK). Reported fact
What deteriorated
-
↓
Operating result weakened
Operating result -17.75m NOK → -27.30m NOK (op. margin -33.6% → -40.5%). Calculated
-
↓
Net result weakened
Net result -16.66m NOK → -23.54m NOK (net margin -31.6% → -34.9%). Calculated
-
↓
Cash fell
Bank deposits 6.83m NOK → 2.92m NOK (-57.3% YoY). Calculated
Things to notice
-
·
Payroll increased
Salary cost 40.17m NOK → 41.36m NOK (76% → 61% of revenue). Calculated
-
·
COGS fell
COGS / varekostnad 322.56m NOK → 11.35m NOK (-96.5% YoY). Calculated